Civi Biopharma, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2a Study to Assess CIVI 007 in Patients on a Background of Statin Therapy (NCT04164888) | Civi Biopharma, Inc. | 2019-11-11 |
| Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3) (NCT04040322) | Civi Biopharma, Inc. | 2019-10-14 |
| Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2) (NCT03867097) | Civi Biopharma, Inc. | 2019-03-07 |
| A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol Level (NCT03427710) | Civi Biopharma, Inc. | 2018-02-07 |
Track Civi Biopharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.